Leukemia Research
Volume 26, Issue 11 , Pages 1011-1016 , November 2002

The kinase inhibitor STI571 reverses the Bcr–Abl induced point mutation frequencies observed in pre-leukemic P190Bcr–Abl transgenic mice

Received 22 May 2001 ,Accepted 22 October 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(01)00181-3

Leukemia Research
Volume 26, Issue 11 , Pages 1011-1016 , November 2002

Article Tools

* Image Usage & Resolution